Recombinant anti-Epidermal Growth Factor Receptor antibody compositions

Details for Australian Patent Application No. 2009287163 (hide)

Owner Symphogen A/S

Inventors Pedersen, Mikkel Wandahl; Kragh, Michael; Hey, Adam S.; Jacobsen, Helle

Agent Spruson & Ferguson

Pub. Number AU-A-2009287163

PCT Pub. Number WO2010/022736

Priority PA 2008 01202 29.08.08 DK; 61/136,391 02.09.08 US

Filing date 27 August 2009

Wipo publication date 4 March 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/022736 Priority application(s): WO2010/022736

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009287164-Anti-CD5 antibodies

2009287161-Treatment of thrombocytopenia